(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone

(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone Struktur
1156804-89-5
CAS-Nr.
1156804-89-5
Englisch Name:
(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone
Synonyma:
(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone;Methanone, (2-chloro-3-pyridinyl)[3-(hydroxymethyl)-1-piperidinyl]-
CBNumber:
CB82575113
Summenformel:
C12H15ClN2O2
Molgewicht:
254.71
MOL-Datei:
1156804-89-5.mol

(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone Eigenschaften

Sicherheit

(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone Chemische Eigenschaften,Einsatz,Produktion Methoden

(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131980 58
Meryer (Shanghai) Chemical Technology Co., Ltd. 021-61259108 18621169109
market03@meryer.com China 40240 62
Amber MolTech LLC 086-010-62176588
amber@jyamber.com China 10152 56
BePharm Ltd 400-685-9117
market@bepharm.com China 15081 60
Beijing Shuoqi Science And Technology Co., Ltd. 18610542700
3138545@qq.com China 298 58
Shanghai Xiushi Biomedical Co., LTD 15021598081,571034478; 15021598081
product001@xiushipharm.com China 4191 58
Shanghai Sunway Pharmaceutical Technology Co.,Ltd. 021-51816796-820 13611835272
sales2@sunwaypharm.com China 44486 58
Bide Pharmatech Ltd. 400-1647117 15221909166
product02@bidepharm.com China 63720 58
BEIJINGYIWANJINGRUI 15866847540
dengyt2000@163.com China 4084 58

  • (2-Chloro-pyridin-3-yl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone
  • Methanone, (2-chloro-3-pyridinyl)[3-(hydroxymethyl)-1-piperidinyl]-
  • 1156804-89-5
Copyright 2019 © ChemicalBook. All rights reserved